MedPath

Oral S-1 plus hepatic arterial infusion chemotherapy with gemcitabine for postoperative liver metastasis from pancreatic cancer

Phase 1
Conditions
Postoperative liver metastases from pancreatic cancer
Registration Number
JPRN-UMIN000011060
Lead Sponsor
Department of Gastroenterological Surgery, Kanazawa University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
12
Inclusion Criteria

Not provided

Exclusion Criteria

Another metastatic lesions.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Prolongation of overall survival
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath